“…This variation could be due that sample size in the present study was larger than the previously reported one. This study HSV 2 seroprevalence (35.2%) in pregnant women was higher to that reported for Italy (7.6-8.4%) [24], China (10.8%) [26], Indonesia (9.9%) [27], Bangladesh (9.91%) [28], and UK (10.4%) [29], Tanzania (20.7%) [30], Australia (30%) [31], USA (22%) [32], Switzerland (21.2%) [33], Canada (17.3%) [34], Senegal (22%) [35], Belgium (18.2%) [36], China (23.5%) [37], and Korea (17%) [38], Turkey (4.4%-5%) [39,40], Kashmir (7.5%) [41], India (8.7%) [42], Croatia (6.8%) [43]. In contrast to our study, a much higher HSV 2 seroprevalence has been reported from Zimbabwe (51.1%) [44], Germany (82%) [45], Turkey (63.1%) [46], and Iran (43.75%) [47].…”